Related Experiment Video
Updated: Mar 2, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left Atrial Thrombosis Despite Dabigatran Therapy.
Anil Pandit1, Fayaz A Hakim1, Komandoor Srivathsan1
1Division of Cardiovascular Diseases Mayo Clinic in Arizona.
Dabigatran, a novel anticoagulant, showed potential safety and efficacy concerns. A patient developed left atrial thrombosis despite taking dabigatran, questioning its use during cardioversion and ablation.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Dabigatran is a novel oral anticoagulant approved for non-valvular atrial fibrillation.
- Its use has increased significantly following FDA approval for various indications.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

